| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |